Your Cancer, Your Treatment, Your Voice.

Shaping the Future of Cancer Care

At OncoOptima, we help patients and care teams compare therapy options head-to-head using functional insights so conversations and treatment decisions are more informed and truly personalized.

CMS CLIA certification badgeHigh complexity
CLIA-certified laboratory
Patient — older womanPatient — older manPatient — womanPatient — older man

Empower Informed Decisions in Cancer Treatment

With many available therapies, it can be hard to know what’s most likely to help—and what might bring side effects without benefit. Choosing well often requires understanding tumor biology, expected effectiveness, and tolerance.

~86%

of cancer patients aren’t eligible for targeted therapy due to mutation status

Volume 32, Issue 7, p926-932, July 2021.

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

View Article on www.annalsofoncology.org

10+

FDA-approved therapy options exist for many cancers — knowing which works best matters

Bladder Cancer

NCCN Guidelines for Patients: Bladder Cancer

View Article on www.nccn.org

TRUSTED BY LEADING CANCER INSTITUTIONS

UT Southwestern Medical Center logoUChicago Medicine logoUI Health logo

Collaborating with top cancer institutions in the country, including NCCN centers, to bridge the gap between research and clinical outcomes.

Your Cancer, Your Treatment, Your Voice

With many available therapies, choosing a path forward can feel overwhelming. Understanding how your cancer cells respond to different therapies can bring clarity to those conversations with your doctor.

Minimize trial and error, test your cancer first

Before committing to a therapy, know how your cancer actually responds to it

Benefit: reduce treatment trial and error

Avoid hidden costs of ineffective treatment

The wrong therapy doesn’t just cost time — it may lead to unnecessary toxicity and could make tumors more resistant to future options.

Benefit: avoid hidden costs

Approach treatment with confidence

When your oncologist has therapy activity data specific to your cancer, treatment conversations can start from a place of clarity.

Benefit: approach treatment with confidence

OncoChoice®

Data as Unique as Your Cancer

OncoChoice® is a high-complexity, CLIA-certified laboratory test designed to assess how cancer cells from your biospecimen respond to therapies your doctor is considering — providing patient-specific drug activity data before treatment begins.

Learn about OncoChoice®